Inventor · disambiguated record
Naveen Mehta
Also filed as: MEHTA NAVEEN · MEHTA NAVEEN K
4 granted patents·7 pending applications·5 citations·filing 2017–2025
60Inventor score
Files withMASSACHUSETTS INST TECHNOLOGY5CULLINAN THERAPEUTICS INC2CULLINAN AMBER CORP1CULLINAN MAN INC1CULLINAN MICA CORP1
Top patents by PatentIndex Score
11 records- 0191US11448643B2Methods to specifically profile protease activity at lymph nodesMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Granted Sep 20, 2022·5 cites·16 claims
- 0272US2023040528A1Methods to specifically profile protease activity at lymph nodesMASSACHUSETTS INST TECHNOLOGY·Filed 2022·Application pending·0 cites
- 0356US2025340651A1Anti-mica/b antibodies with enhanced effector function and methods of useCULLINAN MICA CORP·Filed 2023·Application pending·0 cites
- 0454US2024101630A1Bi-functional linear fusion collagen-localized immunomodulatory molecules and methods thereofCULLINAN AMBER CORP·Filed 2021·Application pending·0 cites
- 0548US12404328B2Multi-specific binding proteins and methods of use thereofCULLINAN MAN INC·Filed 2019·Granted Sep 2, 2025·0 cites·26 claims
- 0648US2025179181A1Multi-specific binding proteins and methods of use thereofCULLINAN THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0747US12433954B2Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifsMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Granted Oct 7, 2025·0 cites·23 claims
- 0846US2021340524A1Methods for identifying chimeric antigen receptor-targeting ligands and uses thereofMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Application pending·0 cites
- 0946US2023032087A1Anti-serum albumin antibodiesCULLINAN ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1042US2017252417A1Protein-chaperoned t-cell vaccinesMASSACHUSETTS INST TECHNOLOGY·Filed 2017·Application pending·0 cites
- 1141US12428480B2Anti-CD19 antibodies and multi-specific binding proteinsCULLINAN THERAPEUTICS INC·Filed 2020·Granted Sep 30, 2025·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →